# Diabetic kidney disease in northwest Ethiopia: Prevalence and determinants among adults with type 2 diabetes

**Authors:** Workagegnehu Hailu, Tadesse Asmamaw Dejene, Markeshaw Tiruneh, Meseret Derbew Molla, Eshetie Melese Birru, Shitaye Alemu, Tadesse Awoke, Francesca D'Addio, Francesca D'Addio, Francesca D'Addio

PMC · DOI: 10.1371/journal.pone.0343210 · PLOS One · 2026-02-20

## TL;DR

This study finds that nearly 37% of type 2 diabetes patients in northwest Ethiopia have diabetic kidney disease, with poor blood pressure and glycemic control being key risk factors.

## Contribution

The study provides the first detailed assessment of DKD prevalence in Ethiopia using reliable diagnostic markers like albuminuria and eGFR.

## Key findings

- The prevalence of DKD among T2DM patients was 37.3%.
- Poor glycemic control and longer diabetes duration were strongly associated with DKD.
- Urban residence was linked to a lower risk of DKD.

## Abstract

Diabetic kidney disease (DKD), mainly due to type 2 diabetes (T2DM) is the leading cause of end-stage kidney disease globally. However, DKD prevalence in sub-Saharan Africa, particularly Ethiopia, is underexplored, especially using reliable markers like quantified albuminuria and cystatin C based estimated glomerular equations (eGFR). This study aimed to assess DKD prevalence and associated factors using multiple diagnostic markers.

A cross-sectional study was conducted in adult T2DM patients at the University of Gondar Comprehensive Specialized Hospital using systematic random sampling. Data on socio-demographics and lab parameters were collected, with DKD diagnosed via eGFR and/or albuminuria (spot urine albumin-to-creatinine ratio and 24-hour collection). SPSS version 28 was used for data analysis, and factors were identified through multivariable logistic regression, with significance at 95% CI and p < 0.05.

In a study of 204 T2DM patients (mean age 60.2 years; 57.4% female), the prevalence of DKD was 37.3% (95% CI: 30.6–44.3). Significant factors associated with DKD included urban residence (AOR = 0.278, p = 0.023), poor blood pressure control (AOR = 2.33, p = 0.016), poor glycemic control (AOR = 2.93, p = 0.007), and longer diabetes duration (AOR = 6.78, p < 0.0001).

This study shows a high prevalence of DKD in T2DM patients, mainly identified via albuminuria. Poor blood pressure control, inadequate glycemic control, and longer diabetes duration were significantly associated with DKD. Regular screening and improved glycemic and blood pressure control are essential to slow DKD progression.

## Linked entities

- **Diseases:** Diabetic kidney disease (MONDO:0005016), type 2 diabetes (MONDO:0005148)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, CST3 (cystatin C) [NCBI Gene 1471] {aka ADLDWA, ARMD11, HEL-S-2}, GLP1R (glucagon like peptide 1 receptor) [NCBI Gene 2740] {aka GLP-1, GLP-1-R, GLP-1R}, ACR (acrosin) [NCBI Gene 49] {aka SPGF87}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}
- **Diseases:** Diabetes (MESH:D003920), kidney failure (MESH:D051437), declining renal function (MESH:D060825), CKD (MESH:D051436), DM (MESH:D009223), Bronchial asthma (MESH:D001249), Chronic hyperglycemia (MESH:D006943), critically ill (MESH:D016638), Gout arthritis (MESH:D006073), dyslipidemia (MESH:D050171), proteinuria (MESH:D011507), metabolic disorder (MESH:D008659), Stroke (MESH:D020521), AKI (MESH:D058186), ESKD (MESH:D007676), ischemic heart disease (MESH:D017202), cardiovascular conditions (MESH:D002318), Albuminuria (MESH:D000419), glomerulosclerosis (MESH:D005921), hypertension (MESH:D006973), Diabetic Kidney Disease (MESH:D003928), endothelial (MESH:D005642), Kidney Disease (MESH:D007674), T2DM (MESH:D003924), Type 1 Diabetes Mellitus (MESH:D003922)
- **Chemicals:** EDTA (MESH:D004492), blood glucose (MESH:D001786), nitric oxide (MESH:D009569), Metformin (MESH:D008687), Sulfonylurea (MESH:D013453), urea (MESH:D014508), SGLT2i (-), Alcohol (MESH:D000438), Creatinine (MESH:D003404), glucose (MESH:D005947)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** A1C

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12923007/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12923007/full.md

## References

41 references — full list in the complete paper: https://tomesphere.com/paper/PMC12923007/full.md

---
Source: https://tomesphere.com/paper/PMC12923007